Browse

You are looking at 41 - 50 of 4,531 items for

  • Refine by Access: All x
Clear All
Full access

CLO24-071: A Propensity Matched Survival Analysis Comparing Partial Versus Radical Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: A National Cancer Database Study

Nathan VanderVeer-Harris, Aden Swayze, Ronscardy Mondesir, Raghuram Reddy, Pushan Prabhakar, Arjun Pon Avudaiappan, Ahmed Eldefrawy, Murugesan Manoharan, and Jorge Caso

Full access

CLO24-072: Length of Hospital Stay, Unplanned Readmission and Mortality for Patients Treated With Partial Nephrectomy or Radical Nephrectomy for Stage I and II Kidney Tumors

Ronscardy Mondesir, Daniel Boaretto, Nathan VanderVeer-Harris, Dianelis Gonzalez Pupo, Pushan Prabhakar, Arjun Pon Avudaiappan, Ahmed Eldefrawy, Murugesan Manoharan, and Jorge Caso

Full access

CLO24-073: Contemporary Treatment Patterns for Patients Diagnosed With cT1a Renal Tumors: A National Cancer Database Study

Dominique Lopez, Aden Swayze, Armin Ghomeshi, Nathan VanderVeer-Harris, Pushan Prabhakar, Arjun Pon Avudaiappan, Ahmed Eldefrawy, Murugesan Manoharan, and Jorge Caso

Full access

CLO24-074: Impact of Neoadjuvant Chemotherapy on Survival and Pathological Response Among Octogenarians Who Underwent Radical Cystectomy for Muscle-Invasive Bladder Cancer

Arjun Pon Avudaiappan, Pushan Prabhakar, Ahmed Eldefrawy, Jorge Caso, and Murugesan Manoharan

Full access

CLO24-075: Surgeon Administered Transversus Abdominis Plane Block With Local Anesthetic Infiltration Versus Transversus Abdominis Plane Block Following Robot-Assisted Radical Prostatectomy

Pushan Prabhakar, Arjun Pon Avudaiappan, Daniel Ajabshir, Orlando Brito Martinez, Ahmed Eldefrawy, Jorge Caso, and Murugesan Manoharan

Full access

CLO24-076: Prolonged Anesthesia as a Risk Factor for Extended Length of Stay Following Craniotomy for Primary Glioma

Samantha Schimmel, Jonah Gordon, Adam Alayli, Gavin Lockard, Anshruta Dhanashekar, Vishnu V. Iyer, Bassel El Sayed, Samuel Bauserman, Nasrin Aldawoodi, Allan Escher, Rahul Mhaskar, and Nam D. Tran

Full access

CLO24-077: Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Immunotherapy: An Analysis of the National Cancer Database (NCDB)

Insija Ilyas Selene, Feitong Lei, Amina Dhahri, Jennifer C. Torres Yee, Bin Huang, Jemin Jose, and Zin Myint

Full access

CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory to/Ineligible for Erythropoiesis Stimulating Agents (ESAs)

Yazan Madanat, Michael R. Savona, Mikkael A. Sekeres, Uwe Platzbecker, Valeria Santini, Pierre Fenaux, Maria Diez-Campelo, David Valcárcel, Tymara Berry, Souria Dougherty, Sheetal Shah, Libo Sun, Ying Wan, Fei Huang, Shyamala Navada, Rami S. Komrokji, and Amer M. Zeidan

Full access

CLO24-080: Association Between Primary Tumor Size and Prognosis in De Novo Metastatic Renal Cell Carcinoma in Patients Who Underwent First Line Immunotherapy-Based Therapy: Real World Data Analysis

Insija Ilyas Selene, Roshmita Bardhan, Rani Jayswal, Amina Dhahri, Jennifer C. Torres Yee, Heidi L. Weiss, Kimberly D. Ratliff, and Zin Myint

Full access

CLO24-081: Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck–Biweekly Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (TPFL) Versus Triweekly TPF: Response Assessment and Translation Into Survival Benefit

Sreevalli Anantharamu, A Sreevalli, Linu Abraham Jacob, Lokanatha Dasappa, Suresh Babu MC, Iokesh KN, Rudresha AH, R. Lakkavalli Krishnappa, and Saldanha Saldanha